ijms-logo

Journal Browser

Journal Browser

Microbiome Connections in Age-Related Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Microbiology".

Deadline for manuscript submissions: 20 May 2026 | Viewed by 6262

Special Issue Editor


E-Mail Website
Guest Editor
1. USF Center for Microbiome Research, Microbiomes Institute, University of South Florida, Tampa, FL 33612, USA
2. Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, FL 33612, USA
Interests: microbiome; gut microbiome; aging-related diseases; Alzheimer’s disease; obesity; diabetes

Special Issue Information

Dear Colleagues,

The microbiome, which consists of a diverse group of bacteria, viruses, archaea, and other microbes present in different regions of the body—primarily in the gut, oral cavity, and skin—forms a symbiotic relationship with its host, playing a significant role in overall health. The composition and interactions of the microbiome are shaped by an individual’s lifestyle and environmental, genetic, and sociodemographic factors throughout life, highlighting its dynamic nature. While aging is a universal process, its impact on physical and intellectual functions varies widely and is influenced by these factors. The microbiome emerges as a crucial element in the progression of age-related health decline and the development of various non-communicable diseases during aging. Chronic low-grade inflammation, often associated with aging and age-related diseases, is frequently triggered by dysregulation of the microflora. This microbiome dysregulation, especially within the gut microbiome, exposes the host to metabolites that influence the inflammatory system, leading to harmful crosstalk between the gut barrier, oral mucosal barrier, and the immune system. This interaction contributes to chronic low-grade inflammation and overall health deterioration. The intricate connection between microbiome dysbiosis and age-related diseases lies in the communication between the microbiome, mucosal barriers, and the systemic immune system, which are closely interconnected.

In this Special Issue, we invite studies that explore the microbiome’s connections with various age-related diseases, including cardiovascular disease, inflammatory bowel disease, obesity, diabetes, musculoskeletal disorders, Alzheimer’s, and dementia. Additionally, we seek to address the potential of restoring microorganisms through lifestyle and dietary interventions to enhance life expectancy and promote healthy aging. This collection of studies aims to uncover the mechanisms by which the microbiome influences aging and to identify strategies to improve health outcomes in older populations.

Dr. Shalini Jain
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • microbiome
  • aging
  • age-related diseases
  • Alzheimer’s
  • dementia

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1382 KB  
Review
Microbiome–Aging–Wrinkles Axis of Skin: Molecular Insights and Microbial Interventions
by Varun Challa, Santosh Kumar Prajapati, Surabhi Gangani, Dhananjay Yadav, Lalitha Lekkala, Shalini Jain and Hariom Yadav
Int. J. Mol. Sci. 2025, 26(20), 10022; https://doi.org/10.3390/ijms262010022 - 15 Oct 2025
Viewed by 2282
Abstract
Skin aging is a complex biological process influenced by both intrinsic factors such as hormonal changes, genetic programming, and immunosenescence and extrinsic stressors including ultraviolet (UV) radiation (particularly UV-A and UV-B), pollution, and lifestyle habits. One of the most prominent manifestations of skin [...] Read more.
Skin aging is a complex biological process influenced by both intrinsic factors such as hormonal changes, genetic programming, and immunosenescence and extrinsic stressors including ultraviolet (UV) radiation (particularly UV-A and UV-B), pollution, and lifestyle habits. One of the most prominent manifestations of skin aging is wrinkle formation, which arises from the progressive degradation of key extracellular matrix (ECM) components like collagen and elastin. Emerging evidence highlights the skin microbiome as a critical, yet underappreciated, modulator of these structural changes. This review summarizes current understanding of how aging alters skin structure and microbial composition, and how these changes contribute to wrinkle development. Age-associated skin is characterized by reduced hydration, sebum production, and barrier integrity, accompanied by a shift in microbial communities. These microbial shifts promote local inflammation, matrix metalloproteinase (MMP) activation, and oxidative stress, all of which accelerate ECM degradation. We further discuss how commensal microbes and their bioactive products such as probiotics and postbiotics can counteract wrinkle formation. Clinical studies support the efficacy of strains such as Lactobacillus plantarum HY7714 and Bifidobacterium breve in improving skin elasticity and reducing wrinkle depth. Additionally, this review highlights the emerging role of microbiome-based interventions in skincare, including oral supplements, topical formulations, and postbiotic-enriched products. Overall, we emphasized the therapeutic potential of microbiome modulation as a novel strategy for maintaining skin health and preventing wrinkle formation during aging. Full article
(This article belongs to the Special Issue Microbiome Connections in Age-Related Diseases)
Show Figures

Figure 1

35 pages, 1294 KB  
Review
Microbiome Engineering for Biotherapeutic in Alzheimer’s Disease Through the Gut–Brain Axis: Potentials and Limitations
by Editha Renesteen, Jacqueline L. Boyajian, Paromita Islam, Amal Kassab, Ahmed Abosalha, Stephanie Makhlouf, Madison Santos, Hongmei Chen, Cedrique Shum-Tim and Satya Prakash
Int. J. Mol. Sci. 2025, 26(11), 5351; https://doi.org/10.3390/ijms26115351 - 2 Jun 2025
Cited by 2 | Viewed by 3531
Abstract
Alzheimer’s disease (AD) is a neurodegenerative condition characterized by considerable cognitive decline and functional impairment, primarily due to the progressive alteration of neurons, microglia, and astrocytes. Pathological manifestations of AD include the loss of synaptic plasticity, reduction in synaptic strength by amyloid-beta, aggregation, [...] Read more.
Alzheimer’s disease (AD) is a neurodegenerative condition characterized by considerable cognitive decline and functional impairment, primarily due to the progressive alteration of neurons, microglia, and astrocytes. Pathological manifestations of AD include the loss of synaptic plasticity, reduction in synaptic strength by amyloid-beta, aggregation, and neurotoxicity from tau protein post-translational modifications, all contributing to the disruption of neural networks. Despite its current pharmacological treatment for AD, different approaches to treat such disease are being developed, from a microbiome perspective. The microbiome encompasses a diverse microorganism, including beneficial bacteria that create a positive impact to diminish AD pathogenesis. Growing evidence suggests that probiotic, prebiotic, synbiotic, and postbiotics can positively modulate the gut–brain axis, reducing systemic inflammation, restoring neurotransmitter balance, and improving gut health, thereby possibly mitigating AD pathogenesis. Moreover, there is paraprobiotics as the most recently developed biotherapeutic with beneficial effects. This review explores the correlation between AD and gut–brain axis as a novel biotherapeutic target. The underlying mechanism of the microbiota–gut–brain axis in AD is examined. Novel insights into the current applications as potential treatment and its limitations are highlighted. Full article
(This article belongs to the Special Issue Microbiome Connections in Age-Related Diseases)
Show Figures

Figure 1

Back to TopTop